79 FR 21 pg. 5388 - Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Filovirus Fusion Proteins and Their Uses
Type: NOTICEVolume: 79Number: 21Page: 5388
Page: 5388FR document: [FR Doc. 2014-01936 Filed 1-30-14; 8:45 am]
Agency: Defense Department
Sub Agency: Army Department
Official PDF Version: PDF Version
[top]
DEPARTMENT OF DEFENSE
Department of the Army
Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Filovirus Fusion Proteins and Their Uses
AGENCY:
Department of the Army, DoD.
ACTION:
Notice.
SUMMARY:
Announcement is made of the availability for licensing of the invention set forth in U.S. Patent Application Serial No. 13/882,041, entitled "Filovirus Fusion Proteins and Their Uses," filed on April 26, 2013. The United States Government, as represented by the Secretary of the Army, has rights to this invention.
ADDRESSES:
Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012.
FOR FURTHER INFORMATION CONTACT:
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619-6664, both at telefax (301) 619-5034.
SUPPLEMENTARY INFORMATION:
The invention relates to the use of the Filovirus glycoprotein fusion proteins for the prevention and diagnosis of Filovirus infection.
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2014-01936 Filed 1-30-14; 8:45 am]
BILLING CODE 3710-08-P